Another study demonstrated that triple-positive EGFR/TP53/RB1 constitute approximately 5% of all EGFR mutant lung adenocarcinoma, and these co-occurring mutations are uniquely associated with high-risk SCLC transformation (seven of 39, 18%) and poor survival (38). Here, EGFR is linked to lung adenocarcinoma.